1. Stcinhauslin F, Wauters JP. Quantification of proteinuria in kidney transplant recipients: Accuracy of the urine protein/creatinine ratio. Clin Nephrol 1995; 43:110.
2. Robinson RR. Isolated proteinuria in asymptomatic patients. Kidney Int 1980; 18:395.
3. Poortmans JR. Postexercise proteinuria in humans. Facts and mechanisms. JAMA 1985; 253:236.
4. Poortmans JR, Brauman H, StaroukineM et al. Indi¬rect evidence of glomerular/tubular mixed-type post-exercise proteinuria in healthy humans. Am J Physiol 1988;254:F277.
5. Carrie BJ, Hilberman M, Schroeder JS, Myers BD. Albuminuria and permselective properties of glomeru-lus in cardiac failure. Kidney Int 1980; 17:507
6. Cameron JS, Turner DS, Ogg GS, Chantler C, Wil¬liams DG. The long term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol
1978; 10:213-18.
7. Row PG, Cameron JS, Turner DR, Evans DJ, White RHR, Ogg CS, et al. Membranous nephropathy. Long term follow-up and association with neoplasia. Q J Med 1975;44:207-9.
8. Brenner BM, Meyer TW, Hostetter TH. Dietary pro¬tein intake and the progressive nature of kidney dis¬ease: the role of hemodynamically mediated glomeru-lar injury in the pathogenesis of progressive glomeru-lar sclerosis in aging, renal ablation and intrinsic renal
disease. N Eng J Med 1982; 307:652-9.
9. Boher MP, Deen WM, Robertson CR, Brenner BM.
Mechanism of angiotensin II induced proteinuria in
the rat. Am J Physiol 1977; 233:F13-21.
10. Remuzzi G, Bertani T. Is glomerulosclerosis a conse¬quence of altered glomerular permeability to macro-
molecules? Kidney Int 1990; 38:384-94.
11. D'Amico G, Ferrario F, Rastaldi MP. Tubulointersti-tial damage in glomerular diseases: it's role in pro¬gression of renal damage. Am J Kidney Dis 1995; 26:124-32.
12. Kees-Folts D, Sadow JL, Schreiner GF. Tubular ca-tabolism of albumin is associated with release of an
inflammatory lipid. Kidney Int 1994; 45:1697-1709.
13. Biancone L, David S, Delia Pietra V, Montrucchio G, Cambi V, Camussi G. Alternative pathway activation of complement by cultured human proximal tubular
epithelial cells. Kidney Int 1994; 45:451-60.
14. Burton C, Harris KPG. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis
1996; 27:765.
15. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A et al. Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995; 26:934-41.
16. Wang Y, Chen J, Chen L, Tay Y-C, Rangan GK, Har¬ris DCH. Induction of monocyte chemoattractant pro-
131
tein-
1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997; 8:1537-45.
17. Zoja C. Donadelli R, Colleoni S, Figliuzzi M. Bonaz-zola S, Morigi M, Remuzzi G. Protein overload stimu¬lates RANTES production by proximal tubular cells depending on NF-kB activation. Kidney Int 1998: 53:1608-15.
18. Remuzzi G, Bertani T. Pathophysiology of progres¬sive nephropathies. N Eng J Med 1998; 339:1448-56.
19. Barnes PJ, Karin M. Nuclear factor-kB: a pivotal transcription factor in chronic inflammatory disease. N Eng J Med 1997;336:1066-1071.
20. Van Kooten C, Gerritsma JSJ, Paape MA, Van Es LA, Banchereau J, Daha MR. Possible role for CD40-CD40L in the regulation of interstitial infiltration in
the kidney. Kidney Int 1997; 51:711 -721.
21. Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G, on behalf of the "Gruppo Italiano Di Studi Epidemiologici In Nefrolo-gia" (GISEN). Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. Kidney Int 1997; 52 (SuppI 63):S54-57.
22. Modification of diet in renal disease study group. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease
study. Kidney Int 1997; 52:778.
23. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M et al. ACE Inhibition in Progressive Renal Insufficiency study group. Effect of the angio-tensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency: the Angio-tensin-Converting Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996;
334: 939-945.
24. Meyer TW, Anderson SA, Renke HG, Brenner BM.
Reversing glomerular hypertension stabilizes estab¬lished glomerular injury. Kidney Int 1987; 31:752.
25. Zatz R, Meyer TW, Renke HG, Brenner BM. Pre¬dominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic nephropathy
Proc Natl Acad Sci USA1985; 82:5963.
26. Miller PL, Scholey JW, Renke HG, Meyer TW.
Glomerular hypertrophy aggravates epithelial cell injury in nephrotic rats. J Clin Invest 1990; 85:1119.
27. Fukui, M, Nakamura, T, Ebihara, I, et al. Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-B in experimental glomerular sclerosis. J Lab Clin
Med 1993; 121:224.
28. Nakamura T, Fukui M, Ebihara I, et al. Low protein diet blunts the rise in glomerular gene expression in focal glomerulosclerosis. Kidney Int 1994; 45:1593.
29. Mitch WE. Dietary protein restriction in chronic renal failure: Nutritional efficacy, compliance, and progres¬sion of renal insufficiency. J Am Soc Nephrol 1991;
2:823. t
30. - Walser M, Mitch WE, Maroni BJ, Kopple JD. Should
protein intake be restricted in predialysis patients?
Kidney Int 1999; 55:771.
31. Aparicio M, Chauveau P, De Precigout, VD, et al. Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a sup¬plemented very low protein diet. J Am Soc Nephrol
2000; 11:708.
32. Kaysen GA, Davies RW, Hutchison FN. Effect of
dietary protein intake and angiotensin converting enzyme inhibition in Heymann nephritis. Kidney Int 1989;(Suppl27):S154.
33. Kaysen GA, Jones H, Jr Martin, V Hutchison, FN. A
low-protein diet restricts albumin synthesis in nephrotic rats. J Clin Invest 1989; 83:1623.
34. Choi EJ, Bailey J, May RC, et al. Metabolic responses to nephrosis: Effect of a low-protein diet. Am J
Physiol 1994;266:F432.
35. Maroni BJ, Staffeld C, Young VR, et al. Mechanisms permitting nephrotic patients to achieve nitrogen equi¬librium with a protein-restricted diet. J Clin Invest
1997; 99:2479.
36. ikizler TA, Greene JH, Wingard RL, et al. Spontane¬ous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 1995; 6:1386.
37. Zeller K, Whittaker E, Sullivan L, et al. Effect of
restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes
mellitus. N Engl J Med 1991; 324:78.
38. Walker JD, Bending JJ, Dodds RA, et al. Restriction
of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989; 2:1411.
39. Ihle BU, Becker GJ, Whitworth JA, et al. The effect
of protein restriction on the progression of renal insuf¬ficiency. N Engl J Med 1989; 321:1773.
40. Locatelli F, Alberti D, Graziani G, et al. Prospective, randomized, multicentre trial of effect of protein re¬striction on progression of chronic renal insufficiency. Lancet 1991; 337:1299.
41. Pedrini MT, Levey AS, Lau J, et al. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-
analysis. Ann Intern Med 1996; 124:627.
42. Kasiske BL, Lakatua JD, Ma JZ, Louis TA. A meta-
analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis
1998; 31:954.
43. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The
effect of angiotensin-converting enzyme inhibition on
diabetic nephropathy. N Engl J Med 1993; 329:1456.
44. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw, D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989; 36:272.
45. Bedogna V, Valvo E, Casagrande P, et al. Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function. Kidney Int 1990; 38:101.
132
46. Gansevoort RT, Sluiter WJ. Hemmelder MH, et al. Antiproteinuric effect of blood-pressure-lowering agents: A meta-analysis of comparative trials. Nephrol
Dial Transplant 1995; 10:1963.
47. Kloke HJ, Wefzels JF. van Hamersvelt HW, et al.
Angiotensin-converting enzyme inhibition and the combination of a beta-blocker and a diuretic are equally effective in lowering proteinuria in patients with glomerulonephritis. Nephrol Dial Transplant
1993:8:808.
48. Lafayette RA, Mayer G, Park SK, Meyer TW. Angio-
tensin II receptors blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992; 90:766.
49. Ichikawa I. Will angiotensin II receptor antagonists be renoprotective in humans. Kidney Int 1996; 50:684.
50. Hutchison FN, Cm X, Webster SK. The antiproteinu-ric action of angiotensin-converting enzyme in de¬pendent on kinin. J Am Soc Nephrol 1995; 6:1216.
51. Russo D, Pisani A, Balletta MM, et al. Additive anti-proteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropa-
thy. Am J Kidney Dis 1999; 33:851.
52. Vriesendorp R, Donker AJ, de Zeeuw D, et al. Effects of nonsteroidal anti-inflammatory drugs on proteinu-
ria. Am J Med 1986:81:84.
53. Shemesh O, Ross JC, Deen WM, et al. Nature of the
glomerular capillary injury in human membranous glomerulopathy. J Clin Invest 1986; 77:868.
54. Heeg JE, de Jong PE de Zeeuw D. Additive antipro-leinuric effect of angiotensin-converting enzyme inhi¬bition and non-steroidal anti-inflammatory drug ther¬apy: A clue to the mechanism of action. Clin Sci 1991; 81:367.
133
Thank you for copying data from http://www.arastirmax.com
